Primary bladder cancer is a frequent malignancy in the urology field, whereas secondary bladder neoplasms from a distant organ are extremely rare. This paper aims to report two rare cases of a secondary tumor of the urinary bladder from a primary gastric tumor and to perform a literature review of similar reported cases in order to better characterize its clinicopathological features and diagnosis in effort to shed light on this rare condition. The final diagnosis of secondary adenocarcinoma was made histologically after transurethral biopsy or resection of the bladder lesion. In one case, the bladder metastasis was a synchronous metastasis, and in the second case, it occurred under chemotherapy five months after initial diagnosis with gastric adenocarcinoma. Secondary adenocarcinoma of the bladder is extremely rare but should be considered when evaluating a bladder lesion in a patient treated for gastric cancer or presenting with gastric symptoms.
RésuméLa cystite gangréneuse compliquée d'une perforation en intrapéri-tonéal est une pathologie extrêmement rare. Le facteur étiopatho-génique principal est l'ischémie de la paroi vésicale. L'intoxication alcoolique comme facteur à l'origine d'une ischémie pariétale cons titue un mécanisme complexe mais grave du fait de l'étendue des lésions et du terrain sur lequel se greffe cette complication. Ce cas clinique rapporte l'observation d'un patient de 36 ans, alcoolique chronique, hospitalisé en raison d'un tableau clinique de péritonite aiguë; L'exploration chirurgicale a révélé une gangrène localisée de la vessie à l'origine d'une perforation spontanée en intrapéritonéal. Après réparation chirurgicale, la fonction et la capacité vésicales sont revenues à la normale.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.